Detalles de la búsqueda
1.
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.
Am J Hematol
; 97(1): E24-E27, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34731510
2.
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.
Clin Pharmacol Drug Dev
; 11(11): 1294-1307, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029150
3.
Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma.
Clin Lung Cancer
; 20(2): 74-81.e1, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30528315
4.
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
J Clin Oncol
; 23(25): 5892-9, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16043829
5.
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
J Clin Oncol
; 23(11): 2544-55, 2005 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15753462
6.
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol
; 23(25): 5900-9, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16043828
7.
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib.
J Clin Pharmacol
; 56(9): 1130-40, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26865195
8.
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.
J Clin Oncol
; 34(25): 3005-13, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27400947
9.
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities.
Clin Cancer Res
; 10(19): 6522-7, 2004 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15475439
10.
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
J Clin Oncol
; 25(30): 4743-50, 2007 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17909199
Resultados
1 -
10
de 10
1
Próxima >
>>